Position in HIMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,771,722
+$2,315,681 QoQ
Shares Held
166,476
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#97
of 506 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $163,229,385 across 12 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
580,039 | $41,681,601 | |
| 2 | VTRS |
Viatris Inc
|
2,528,381 | $40,150,689 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
48,445 | $26,248,953 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
569,466 | $19,293,507 | |
| 5 | HCM |
HUTCHMED (China) Ltd
|
837,475 | $9,011,231 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
335,594 | $8,258,968 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
166,476 | $5,771,722 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
543,781 | $4,556,884 |
All Filings in HIMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,771,722 | 166,476 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,456,041 | 166,476 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,827,455 | 179,472 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,979,187 | 34,894 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,922,954 | 58,635 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $3,030,766 | 102,564 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $3,202,544 | 132,446 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $550,739 | 29,899 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||